Literature DB >> 3404192

The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.

G K Wilcock1, M M Esiri, D M Bowen, A O Hughes.   

Abstract

Cell counts have been performed on cholinergic subcortical nuclei, dorsal raphe nucleus, and locus caeruleus from up to 18 cases of Alzheimer's disease and 10 age-matched control subjects. In general, the extent of cell loss in these structures was similar. In the basal nucleus the anteromedial subdivision was the least, and the posterior subdivision the most affected. A subgroup of demented subjects with Alzheimer's disease had a relatively preserved basal nucleus, and frontal lobe (CAT) choline acetyltransferase activities similar to those in control subjects, but significantly more neuronal loss in the locus caeruleus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3404192      PMCID: PMC1033158          DOI: 10.1136/jnnp.51.6.842

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  39 in total

1.  Efferent projections of nucleus locus coeruleus: morphologic subpopulations have different efferent targets.

Authors:  S E Loughlin; S L Foote; R Grzanna
Journal:  Neuroscience       Date:  1986-06       Impact factor: 3.590

2.  A comparison of nerve cell loss in cortical and subcortical structures in Alzheimer's disease.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

3.  Alzheimer plaques and cortical cholinergic innervation.

Authors:  T Arendt; V Bigl
Journal:  Neuroscience       Date:  1986       Impact factor: 3.590

4.  Alzheimer plaques and cortical cholinergic innervation.

Authors:  M M Mesulam
Journal:  Neuroscience       Date:  1986       Impact factor: 3.590

5.  The Klüver-Bucy Syndrome in man. A clinico-anatomical contribution to the function of the medial temporal lobe structures.

Authors:  G Pilleri
Journal:  Psychiatr Neurol (Basel)       Date:  1966

6.  Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Neurosci Lett       Date:  1985-05-01       Impact factor: 3.046

7.  A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease.

Authors:  M Tabaton; A Schenone; P Romagnoli; G L Mancardi
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density.

Authors:  C A Curcio; T Kemper
Journal:  J Neuropathol Exp Neurol       Date:  1984-07       Impact factor: 3.685

9.  Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons.

Authors:  T Yamamoto; A Hirano
Journal:  Ann Neurol       Date:  1985-06       Impact factor: 10.422

10.  Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged.

Authors:  B Marcyniuk; D M Mann; P O Yates
Journal:  Neurosci Lett       Date:  1986-03-14       Impact factor: 3.046

View more
  18 in total

1.  Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation.

Authors:  Q Chen; H Yoshida; D Schubert; P Maher; M Mallory; E Masliah
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease.

Authors:  Michael T Heneka; Elena Galea; Vitaliy Gavriluyk; Lucia Dumitrescu-Ozimek; JoAnna Daeschner; M Kerry O'Banion; Guy Weinberg; Thomas Klockgether; Douglas L Feinstein
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

3.  Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease.

Authors:  Markus Morawski; Maike Hartlage-Rübsamen; Carsten Jäger; Alexander Waniek; Stephan Schilling; Claudia Schwab; Patrick L McGeer; Thomas Arendt; Hans-Ulrich Demuth; Steffen Rossner
Journal:  Acta Neuropathol       Date:  2010-04-10       Impact factor: 17.088

4.  Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan Teipel
Journal:  Neurobiol Aging       Date:  2012-11-15       Impact factor: 4.673

5.  Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease.

Authors:  Chelsea T Tiernan; Elliott J Mufson; Nicholas M Kanaan; Scott E Counts
Journal:  J Neuropathol Exp Neurol       Date:  2018-03-01       Impact factor: 3.685

6.  Expression of the CD15 epitope in the human magnocellular basal forebrain system.

Authors:  S A Morres; J K Mai; L Teckhaus
Journal:  Histochem J       Date:  1992-11

7.  Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation.

Authors:  G M Halliday; H L McCann; R Pamphlett; W S Brooks; H Creasey; E McCusker; R G Cotton; G A Broe; C G Harper
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 8.  Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2016-06-23       Impact factor: 3.911

9.  Does Alzheimer's disease begin in the brainstem?

Authors:  G Simic; G Stanic; M Mladinov; N Jovanov-Milosevic; I Kostovic; P R Hof
Journal:  Neuropathol Appl Neurobiol       Date:  2009-08-04       Impact factor: 8.090

Review 10.  APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.

Authors:  Leslie Crews; Edward Rockenstein; Eliezer Masliah
Journal:  Brain Struct Funct       Date:  2009-11-29       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.